Initial experiences with dynamic, quality indicator-based multimodal tissue analysis (M-Ref) with parallel assessment of viscosity and shear wave elastography in liver parenchyma alterations

Ernst Michael Jung(University Hospital Regensburg), F. Jung(Brandenburg University of Technology Cottbus-Senftenberg), Ulrich Kaiser(University of Applied Sciences Landshut), Isabel Wiesinger(University Hospital Regensburg)
Clinical Hemorheology and Microcirculation
December 23, 2024
10.3233/ch-248111
Cited by 5

Related Papers

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
|The Lancet|2013|1.5k
Vascular Endothelial Cell Biology: An Update
|International Journal of Molecular Sciences|2019|1.1k
Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial
|The Lancet Oncology|2015|402
Incidence and risk factors of central nervous system recurrence in aggressive lymphoma—a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)
|Annals of Oncology|2006|280
<i>CEBPA</i> mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome
|Blood|2021|170